# Genelux Corporation (GNLX) Genelux Corporation (GNLX) sees a surge in social mentions and creator activity, with significant increases in social dominance. The company is advancing clinical trials, but market sentiment and valuation concerns are impacting its stock price. ### About Genelux Corporation Genelux Corporation is a biotechnology company focused on developing novel cancer therapies. Genelux Corporation uses the ticker $GNLX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Genelux Corporation (GNLX) mentions hit [--] which is 332% higher than it's daily average. - Genelux Corporation (GNLX) creators hit [--] which is 207% higher than it's daily average. - Genelux Corporation (GNLX) social dominance hit [------] which is 283% higher than it's daily average. - Genelux Corporation (GNLX) market cap is up 11.11% from the previous week. - Genelux Corporation (GNLX) social dominance is up 1920% from the previous [--] months. - Genelux Corporation (GNLX) Galaxy Score™ is up 113.04% from the previous week. ### Price: $2.60  [Price 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/close.tsv) The stock price has declined by -31.35% over the last [--] days, attributed to a market sentiment shift and valuation concerns, overriding positive news about clinical trial progress. The current price of $2.40 is near its 1-year low. 24-Hour: 4.82% 7-Day: 9.66% 30-Day: -4.74% 1-Year High: $8.20 on 2025-11-03 1-Year Low: $2.40 on 2026-02-05 ### AltRank: [-----]  [AltRank 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/alt_rank.tsv) Genelux Corporation (GNLX) is currently AltRank #2,481 based on combined combined social and market metrics Daily Average: [-----] [--] Week: [-----] +221 1-Year High: [-----] on 2026-01-27 1-Year Low: [---] on 2026-01-25 ### Galaxy Score: [--]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/galaxy_score.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] +26 1-Year High: [--] on 2026-01-25 1-Year Low: [--] on 2026-01-28 ### Engagements: [---] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/interactions.tsv) Current Value: [---] Daily Average: [-----] [--] Week: [-----] -7.50% [--] Month: [-----] -95% [--] Months: [-------] +28% [--] Year: [-------] -13% 1-Year High: [------] on 2025-12-15 1-Year Low: [--] on 2025-08-09 Engagements by network (24h): X: [---] Reddit: [--] News: [---] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] -4.80% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-08-09 Mentions by network (24h): X: [--] Reddit: [--] News: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Genelux Corporation (GNLX) in the last [--] hours which is up 360% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [--] -13% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-08-09 ### Sentiment: 67%  [Sentiment 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/sentiment.tsv) Current Value: 67% Daily Average: 85% [--] Week: 57% -43% [--] Month: 60% +10% [--] Months: 60% -40% [--] Year: 60% -7% 1-Year High: 100% on 2025-02-16 1-Year Low: 10% on 2025-06-14 Most Supportive Themes: - Clinical Trial Progress: (40%) Genelux Corporation is advancing its clinical trials, with a recent announcement about dosing the first patient in a Phase [--] trial for Non-Small Cell Lung Cancer. - Financial Performance: (30%) The company has reported its financial results, indicating its ongoing operational and financial standing. - Strategic Partnerships and Conferences: (30%) Genelux Corporation is actively participating in industry conferences and engaging in strategic discussions, as evidenced by their participation in the Guggenheim Healthcare Innovation Conference. Most Critical Themes: - Market Sentiment Shift: (70%) Despite positive news, the stock price has seen a significant decline over the past [--] days, suggesting a potential disconnect between company developments and market valuation. - Valuation Concerns: (30%) The current price is considerably lower than its 1-year high, and the market cap has also seen a decrease, raising questions about the stock's current valuation. ### Social Dominance: 0.00547%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/social_dominance.tsv) Current Value: 0.00547% Daily Average: 0.00248% [--] Week: 0.00542% +0.00502% [--] Month: 0.01% +0.0093% [--] Months: 0.01% +0.0096% [--] Year: 0.01% +0.006% 1-Year High: 0.031% on 2025-06-29 1-Year Low: 0.0001% on 2025-08-09 ### Market Dominance: 0.00013217853443729305%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/market_dominance.tsv) Current Value: 0.00013217853443729305% Daily Average: 0% 1-Year High: 0.00513% on 2026-02-13 1-Year Low: 0.00013% on 2026-02-15 ### Market Cap: $116,715,123  [Market Cap 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/market_cap.tsv) Current Value: $116,715,123 Daily Average: $118,872,130 [--] Week: $116,267,939 +11% [--] Month: $116,715,123 -4.70% 1-Year High: $132,366,576 on 2026-01-27 1-Year Low: $105,088,329 on 2026-02-05 Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
Genelux Corporation (GNLX) sees a surge in social mentions and creator activity, with significant increases in social dominance. The company is advancing clinical trials, but market sentiment and valuation concerns are impacting its stock price.
Genelux Corporation is a biotechnology company focused on developing novel cancer therapies.
Genelux Corporation uses the ticker $GNLX for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price has declined by -31.35% over the last [--] days, attributed to a market sentiment shift and valuation concerns, overriding positive news about clinical trial progress. The current price of $2.40 is near its 1-year low.
24-Hour: 4.82% 7-Day: 9.66% 30-Day: -4.74%
1-Year High: $8.20 on 2025-11-03
1-Year Low: $2.40 on 2026-02-05
AltRank 24-Hour Time-Series Raw Data
Genelux Corporation (GNLX) is currently AltRank #2,481 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] +221
1-Year High: [-----] on 2026-01-27
1-Year Low: [---] on 2026-01-25
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +26
1-Year High: [--] on 2026-01-25
1-Year Low: [--] on 2026-01-28
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -7.50%
[--] Month: [-----] -95%
[--] Months: [-------] +28%
[--] Year: [-------] -13%
1-Year High: [------] on 2025-12-15
1-Year Low: [--] on 2025-08-09
Engagements by network (24h): X: [---] Reddit: [--] News: [---]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -4.80%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-08-09
Mentions by network (24h): X: [--] Reddit: [--] News: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Genelux Corporation (GNLX) in the last [--] hours which is up 360% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] -13%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-08-09
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 85%
[--] Week: 57% -43%
[--] Month: 60% +10%
[--] Months: 60% -40%
[--] Year: 60% -7%
1-Year High: 100% on 2025-02-16
1-Year Low: 10% on 2025-06-14
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00547%
Daily Average: 0.00248%
[--] Week: 0.00542% +0.00502%
[--] Month: 0.01% +0.0093%
[--] Months: 0.01% +0.0096%
[--] Year: 0.01% +0.006%
1-Year High: 0.031% on 2025-06-29
1-Year Low: 0.0001% on 2025-08-09
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00013217853443729305%
Daily Average: 0%
1-Year High: 0.00513% on 2026-02-13
1-Year Low: 0.00013% on 2026-02-15
Market Cap 24-Hour Time-Series Raw Data
Current Value: $116,715,123
Daily Average: $118,872,130
[--] Week: $116,267,939 +11%
[--] Month: $116,715,123 -4.70%
1-Year High: $132,366,576 on 2026-01-27
1-Year Low: $105,088,329 on 2026-02-05
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$gnlx